• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Midatech Pharma ADR (NQ: MTP )

    N/A UNCHANGED
    Last Price Updated: 3:59 PM EDT, Mar 24, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Midatech Pharma ADR

    < Previous 1 2 Next >
    Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease
    Via ACCESSWIRE
    Midatech Pharma PLC Announces Results of General Meeting
    Via ACCESSWIRE
    Midatech Pharma PLC Announces Further re: Notice of General Meeting
    Via ACCESSWIRE
    Midatech Pharma PLC Announces Posting of Circular and Notice of General Meeting
    Via ACCESSWIRE
    Midatech Pharma PLC Announces Closing of $6.0m Private Placement & Broker Change
    Via ACCESSWIRE
    Midatech Pharma PLC Announces Private Placement Raising US $6.0 million
    Via ACCESSWIRE
    Midatech Pharma PLC Announces Result of General Meeting
    Via ACCESSWIRE
    Midatech Pharma PLC Announces Planned Dose Escalation in MTX-110 Phase 1 Study
    Via ACCESSWIRE
    Midatech Pharma PLC Announces Posting of Circular and Notice of General Meeting
    Via ACCESSWIRE
    Midatech Pharma PLC - First Patient Enrolled in Phase 1 Study of MTX-110
    Via ACCESSWIRE
    Midatech Pharma PLC Announces Receipt of NASDAQ Notice
    Via ACCESSWIRE
    Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders
    From Bioasis Technologies Inc.
    Via GlobeNewswire
    Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc
    From Bioasis Technologies Inc.
    Via GlobeNewswire
    Midatech Pharma PLC Announces Closing of Offering, Revised Terms, AIM & Webinar
    Via ACCESSWIRE
    Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc
    US$10M Registered Direct Offering and PIPE to Strengthen Balance Sheet of Combined Company 
    From Bioasis Technologies Inc.
    Via GlobeNewswire
    Midatech Pharma PLC Announces Proposed Acquisition of Bioasis Technologies Inc
    Via ACCESSWIRE
    Midatech Pharma PLC Announces Receipt of NASDAQ Notification
    Via ACCESSWIRE
    Midatech Pharma PLC Announces ADR Ratio Change
    Via ACCESSWIRE
    Midatech Pharma PLC Announces Interim Results for the Six Months to 30 June 2022
    Via ACCESSWIRE
    Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma
    Orphan Designation Granted by EMA to MTX110 Development for the Treatment of Glioma 
    From Midatech Pharma PLC
    Via AccessWire
    Midatech Pharma PLC Announces Retirement of Chairman and Proposed New Chairman
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines,... 
    From Midatech Pharma PLC
    Via AccessWire
    Topics Retirement
    Exposures Pension
    Midatech Pharma PLC - MTX110 Study to be Presented at ISPNO 2022
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines,... 
    From Midatech Pharma PLC
    Via AccessWire
    Midatech Pharma PLC Announces Fast Track Designation for MTX110 Development
    Fast Track Designation Granted to MTX110 Development for the Treatment of Recurrent Glioblastoma 
    From Midatech Pharma PLC
    Via AccessWire
    Exposures Product Safety
    Midatech Pharma PLC Announces Posting of Annual Report & Notice of AGM
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 24, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of... 
    From Midatech Pharma PLC
    Via AccessWire
    Midatech Pharma PLC Announces Results for the Year Ended 31 December 2021
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 26, 2022 / Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines,... 
    From Midatech Pharma PLC
    Via AccessWire
    Midatech Pharma PLC Announces Receipt of NASDAQ Notice
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 14, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of... 
    From Midatech Pharma PLC
    Via AccessWire
    Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule
    ABINGDON, UK / ACCESSWIRE / March 9, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is... 
    From Midatech Pharma PLC
    Via AccessWire
    Midatech Pharma PLC Announces Appointment of Nominated and Financial Adviser
    ABINGDON, UK / ACCESSWIRE / March 8, 2022 / Midatech Pharma PLC (AIM:MTPH; NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicine, is... 
    From Midatech Pharma PLC
    Via AccessWire
    Midatech Pharma PLC Announces IND Application for MTX110 Study in GBM Effective
    Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective ABINGDON, OXFORDSHIRE / ACCESSWIRE / December 13, 2021 / Midatech Pharma PLC... 
    From Midatech Pharma PLC
    Via AccessWire
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    Midatech Pharma PLC Announces Notice of Interim Results
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 6, 2021 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of... 
    From Midatech Pharma PLC
    Via AccessWire
    Topics Intellectual Property
    Exposures Intellectual Property
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.